Cookie Preference

This website uses cookies to improve user experience. Please select an option.  Privacy Policy

No cookies except for those necessary for technical reasons are set.

Search

News

[Translate to English:]

Ascenion’s portfolio company Cardior Pharmaceuticals announced positive results of a Phase Ib study with its first-in-class compound CDR132L.

[Translate to English:]

Ascenion welcomes a new colleague to the Munich office: Stefanie Danzer joined in October 2020 to support the back office in event management and corporate communications.

[Translate to English:]

Ascenion will support eight members and four partners of the Innovative Training Network (ITN) ‘SMABEYOND’ in all aspects relating to the intellectual property and potential commercialization of their work.

[Translate to English:]

Ascenion’s portfolio company iThera gained regulatory approval for a pivotal trial evaluating its MSOT imaging technology for the assessment of colon inflammation. If successful, it could provide a superior, non-invasive alternative to colonoscopy.

[Translate to English:]

How is the German start-up sector doing? Are there ‘zombies’ here too – as in the USA? And what should we be looking out for? A number of heads of German technology transfer organisations were interviewed for this overview, including Ascenion’s Christian Stein.

Supporting start-ups has always been a particular focus of our activities. In 2019, we have seen significant successes and opposing trends in this area. Here our summary of highlights, figures and key developments in the start-up field and beyond.

 

The TransferAllianz proposes 5 measures to leverage the innovation potential of academic research and drive sustainable economic recovery following the corona crisis.

BERLIN, 28 August 2020 – Aignostics, a spin-off from Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) pioneering…

[Translate to English:]
  • T-knife’s proprietary humanized mouse platform (HuTCR) T-cell Receptors expected to provide superior affinity/specificity properties
  • Series A round led by Versant Ventures and RA Capital Management, with strong participation from seed investors Andera Partners and BIVF

HepaRegeniX has demonstrated proof-of-efficacy in acute liver disease in preclinical studies performed in collaboration with the University Hospital of Tübingen (Germany) and the Mayo Clinic (Rochester, MN, USA).

[Translate to English:]

Ascenion welcomes a new colleague to the Munich office: Cristina Romano joined the company as Legal Counsel in July 2020, bringing over 15 years’ professional experience to the team.

Join us on 24 June and on 1 July 2020 for our webinars, presenting the top licensable projects in the field of gene and cell therapy from Ascenion’s and Oxford University Innovation’s (OUI) portfolios.

[Translate to English:]

Dr Julia Niemann joined Ascenion’s team in Hannover in April 2020 as Technology Scout. Her main focus will be on projects at the Hannover Medical…

[Translate to English:]

Newly founded dentalXrai provides a unique, AI-based platform to improve and speed up the analysis of dental X-ray images. Ascenion, technology transfer partner of the Charité – Universitätsmedizin Berlin, holds equity in the start-up.

[Translate to English:]

Diffratec, a spin-off from the Medical University of Innsbruck (MUI), commercializes breakthrough diffractive elements. These elements, in particular Moiré lenses, are extremely compact and tunable with high speed and precision.

Events

BioFIT 2020 Digital

[Translate to English:]

AUTM Annual Meeting 2021 Virtual

[Translate to English:]

BioVaria 2021 Virtual

[Translate to English:]

ASTP Annual Conference 2021

Altis Grand Hotel

Lisbon, Portugal